Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

The multifaceted roles of Zinc in Cancers

Version 1 : Received: 15 September 2022 / Approved: 19 September 2022 / Online: 19 September 2022 (14:05:29 CEST)

A peer-reviewed article of this Preprint also exists.

Bendellaa, M, Lelièvre, P, Coll, J-L, Sancey, L, Deniaud, A, Busser, B. Roles of zinc in cancers: From altered metabolism to therapeutic applications. Int J Cancer. 2023; 1-14. doi:10.1002/ijc.34679 Bendellaa, M, Lelièvre, P, Coll, J-L, Sancey, L, Deniaud, A, Busser, B. Roles of zinc in cancers: From altered metabolism to therapeutic applications. Int J Cancer. 2023; 1-14. doi:10.1002/ijc.34679

Abstract

Zinc (Zn) is a trace element crucial for oxidative stress, apoptosis, the immune response, and more globally for various processes involved in cellular homeostasis. In some cancers, Zn homeostasis is dysregulated. In this review, the role of Zn in cancer and all the components associated to Zn, the use of Zn and Zn -related proteins as biomarkers and Zn-based strategies for the treatment of tumors will be described. ZIP and ZnT are proteins related to Zn metabolism in normal conditions. In cancer, the level of expression of Zn related proteins is abnormal. These Zn proteins may act as prognostic or diagnostic biomarkers, and may be helpful for detecting early-stage cancers or monitoring the course of the disease. Additionally, Zn and its pathways may also be targeted to treat cancers. Indeed, the use of metals for binding Zn cations allows to regulate the biodistribution of Zn within cells, and will control several downstream signaling pathways. Zinc may also be directly used as a therapeutic substance to improve the prognosis of cancer patients, especially with the supplementation of zinc or the use of Zn oxide nanoparticles.

Keywords

Zinc homeostasis; cancer; therapy; prognostic; diagnostic; nanoparticles; biomarkers

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.